Search

Displaying results 9031 - 9040 of 10000 in total
  1. Drug

    Levodropropizine

    go.drugbank.com/drugs/DB12472
    Investigational

    Levodropropizine is under investigation in clinical trial NCT01573663 (A Drug-Drug Interaction Study of Ambroxol and Levodropropizine).

  2. Drug

    Blosozumab

    go.drugbank.com/drugs/DB12560
    Investigational

    Blosozumab has been used in trials studying the basic science and treatment of Osteoporosis and Osteoporosis, Postmenopausal.

  3. Drug

    PSI-352938

    go.drugbank.com/drugs/DB12896
    Investigational

    PSI-352938 has been used in trials studying the treatment of Hepatitis C and Hepatitis C, Chronic.

  4. Drug

    Menaquinone 6

    go.drugbank.com/drugs/DB14936
    Investigational

    Menaquinone 6 is under investigation in clinical trial NCT01194778 (Comparison of Efficacy of Different Dosages Vitamin K2).

  5. Drug

    Pifusertib

    go.drugbank.com/drugs/DB15054
    Investigational

    TAS-117 is under investigation in clinical trial NCT03017521 (K-BASKET, TAS-117, PI3K/AKT Gene Aberration).

  6. Drug

    SB-1578

    go.drugbank.com/drugs/DB15294
    Investigational

    SB-1578 is under investigation in clinical trial NCT01235871 (A Single and Multiple-Dose Study of SB1578).

  7. Drug

    Radavirsen

    go.drugbank.com/drugs/DB15332
    Investigational

    Radavirsen is under investigation in clinical trial NCT01375985 (Safety Study of Single Administration Intravenous Treatment for Influenza).

  8. Drug

    (S)-Propafenone

    go.drugbank.com/drugs/DB15410
    Investigational

    (S)-Propafenone is under investigation in clinical trial NCT02710669 (New Formulations of Propafenone to Treat Atrial Fibrillation).

  9. Drug

    Bakuchiol

    go.drugbank.com/drugs/DB16102
    Investigational

    Bakuchiol is under investigation in clinical trial NCT03112863 (Comparison of the Cosmetic Effects of Bakuchiol and Retinol).

  10. Drug

    Pexmetinib

    go.drugbank.com/drugs/DB16294
    Investigational

    Pexmetinib is under investigation in clinical trial NCT04074967 (Study of ARRY-614 Plus Either Nivolumab or Ipilimumab).